Sunday, 16 February 2020 / Published in NMPA
On 11.02.2020, the Israel Export Institute co-hosted a webinar together with Cisema. In this webinar, the China administration bodies, regulations and standards for cosmetics were introduced by our business consultant, Anna King, as well as a presentation of the important prerequisites for NMPA registration in China. An overview of the approval systems for special and
Sunday, 09 February 2020 / Published in CCC, Quality assurance & supplier development
On 04.02.2020, the authorities SAMR (State Administration for Market Regulation) and CNCA (China National Certification Administration) published in their Notice No 9/2020 general support measures to contain the corona virus outbreak. Chinese certification organizations are bound by these requirements. The measures include: Processes are to be optimized so that personal contact is reduced as much
Tuesday, 28 January 2020 / Published in NMPA
On 23.01.2020, the Ministry of Commerce of the PRC announced (No.3-2020) the list of intermediary services and administrative examinations and approvals for import and export of goods. The China Chamber of Commerce for Import & Export of Medicines and Health Products continues to be responsible for the import quota monitoring of restricted goods in accordance
Friday, 17 January 2020 / Published in MDACS
On 06.11.2019, the Central Goverment of PRC has accepted the HKSAR goverment’s proposal for the use of Hong Kong registered pharmaceutical products and common medical devices in designated Hong Kong-owned medical institutions in the Greater Bay Area. As a facilitation measure for Hong Kong residents working and living in the Greater Bay Area to seek